Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Trade Name
Risk Category
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • antineoplastic.
  • Fetal Risk
    Fetal Risk
  • Using the drug before conception decreases the chance of having a live birth, and probably associated with increased incidence of congenital anomalies in the offsprings.
  • Limited human data but the drug used in 2nd and 3rd trimesters without fetal adverse effects.
  • Exposure to antineoplastic agents during pregnancy may result in low birth weight babies, but effects of this drug on fetal mental and growth development were not studied.
  • Occupational exposure of the mother to antineoplastic agents during pregnancy carries risks to the fetus, increasing fetal loss and congenital anomalies.
  • Breast Feeding
    Breast Feeding
  • Unknown excretion into breast milk
  • Use in nursing mothers is not recommended.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     2   +   4    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year